650 related articles for article (PubMed ID: 15722637)
21. [Systemic mastocytosis].
Niedoszytko M; Lange M; Chelminska M; Jaśkiewicz K; Piskosz A; Wasag B; Lewandowski K; Mital A; Renke J; Gruchała-Niedoszytko M; Woźniak M; Babińska A; Jassem E
Pneumonol Alergol Pol; 2005; 73(3):239-44. PubMed ID: 16989160
[TBL] [Abstract][Full Text] [Related]
22. Serum tryptase correlates with the KIT D816V mutation burden in adults with indolent systemic mastocytosis.
Kristensen T; Broesby-Olsen S; Vestergaard H; Bindslev-Jensen C; Møller MB;
Eur J Haematol; 2013 Aug; 91(2):106-11. PubMed ID: 23621866
[TBL] [Abstract][Full Text] [Related]
23. A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val.
Jordan JH; Fritsche-Polanz R; Sperr WR; Mitterbauer G; Födinger M; Schernthaner GH; Christian Bankl H; Gebhart W; Chott A; Lechner K; Valent P
Leuk Res; 2001 Jul; 25(7):627-34. PubMed ID: 11377687
[TBL] [Abstract][Full Text] [Related]
24. [Anaphylactoid reaction in occult systemic mastocytosis. A rare dermatologic emergency ].
Ständer H; Beier K; Metze D; Brehler R
Hautarzt; 2005 Mar; 56(3):265-9. PubMed ID: 15619082
[TBL] [Abstract][Full Text] [Related]
25. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients.
Brockow K; Jofer C; Behrendt H; Ring J
Allergy; 2008 Feb; 63(2):226-32. PubMed ID: 18186813
[TBL] [Abstract][Full Text] [Related]
26. Indolent systemic mastocytosis as the cause of a long history of unexplained hypotensive episodes.
Nora EH; Hamacher KL; Zent CS; Ghosh AK
South Med J; 2006 Aug; 99(8):876-9. PubMed ID: 16929885
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L).
Jordan JH; Walchshofer S; Jurecka W; Mosberger I; Sperr WR; Wolff K; Chott A; Bühring HJ; Lechner K; Horny HP; Valent P
Hum Pathol; 2001 May; 32(5):545-52. PubMed ID: 11381374
[TBL] [Abstract][Full Text] [Related]
28. Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis.
Zanotti R; Bonifacio M; Lucchini G; Sperr WR; Scaffidi L; van Anrooij B; Oude Elberink HN; Rossignol J; Hermine O; Gorska A; Lange M; Hadzijusufovic E; Miething C; Müller S; Perkins C; Shomali W; Elena C; Illerhaus A; Jawhar M; Parente R; Caroppo F; Solomianyi O; Zink A; Mattsson M; Yavuz AS; Panse J; Varkonyi J; Doubek M; Sabato V; Breynaert C; Vucinic V; Schug T; Hägglund H; Wortmann F; Brockow K; Angelova-Fischer I; Belloni Fortina A; Triggiani M; Reiter A; Hartmann K; Malcovati L; Gotlib J; Shoumariyeh K; Niedoszytko M; Arock M; Kluin-Nelemans HC; Bonadonna P; Valent P
Leukemia; 2022 Feb; 36(2):516-524. PubMed ID: 34545185
[TBL] [Abstract][Full Text] [Related]
29. Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients.
Theoharides TC; Boucher W; Spear K
Int Arch Allergy Immunol; 2002 Aug; 128(4):344-50. PubMed ID: 12218373
[TBL] [Abstract][Full Text] [Related]
30. Clonal mast cell proliferation in pruriginous skin in hypereosinophilic syndrome.
Wiednig M; Beham-Schmid C; Kranzelbinder B; Aberer E
Dermatology; 2013; 227(1):67-71. PubMed ID: 24008407
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic value of tryptase in anaphylaxis and mastocytosis.
Schwartz LB
Immunol Allergy Clin North Am; 2006 Aug; 26(3):451-63. PubMed ID: 16931288
[TBL] [Abstract][Full Text] [Related]
32. Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management.
Pardanani A
Am J Hematol; 2013 Jul; 88(7):612-24. PubMed ID: 23720340
[TBL] [Abstract][Full Text] [Related]
33. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis.
Schwartz LB; Metcalfe DD; Miller JS; Earl H; Sullivan T
N Engl J Med; 1987 Jun; 316(26):1622-6. PubMed ID: 3295549
[TBL] [Abstract][Full Text] [Related]
34. Are gastrointestinal mucosal mast cells increased in patients with systemic mastocytosis?
Siegert SI; Diebold J; Ludolph-Hauser D; Löhrs U
Am J Clin Pathol; 2004 Oct; 122(4):560-5. PubMed ID: 15487454
[TBL] [Abstract][Full Text] [Related]
35. Multidisciplinary Challenges in Mastocytosis and How to Address with Personalized Medicine Approaches.
Valent P; Akin C; Gleixner KV; Sperr WR; Reiter A; Arock M; Triggiani M
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31216696
[TBL] [Abstract][Full Text] [Related]
36. Fatal anaphylactic sting reaction in a patient with mastocytosis.
Wagner N; Fritze D; Przybilla B; Hagedorn M; Ruëff F
Int Arch Allergy Immunol; 2008; 146(2):162-3. PubMed ID: 18204283
[TBL] [Abstract][Full Text] [Related]
37. Insect anaphylaxis: addressing clinical challenges.
Tracy JM; Lewis EJ; Demain JG
Curr Opin Allergy Clin Immunol; 2011 Aug; 11(4):332-6. PubMed ID: 21659864
[TBL] [Abstract][Full Text] [Related]
38. The presence of mast cell clonality in patients with unexplained anaphylaxis.
Gülen T; Hägglund H; Sander B; Dahlén B; Nilsson G
Clin Exp Allergy; 2014 Sep; 44(9):1179-87. PubMed ID: 25039926
[TBL] [Abstract][Full Text] [Related]
39. Transglutaminase 2 expressed in mast cells recruited into skin or bone marrow induces the development of pediatric mastocytosis.
Ahn YM; Hong GU; Kim SH; Lee HJ; Baek HS; Kim MN; Park KY; Ro JY
Pediatr Allergy Immunol; 2015 Aug; 26(5):438-45. PubMed ID: 25952500
[TBL] [Abstract][Full Text] [Related]
40. Effector cells of anaphylaxis: mast cells and basophils.
Schwartz LB
Novartis Found Symp; 2004; 257():65-74; discussion 74-9, 98-100, 276-85. PubMed ID: 15025392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
